Skip to main content
. Author manuscript; available in PMC: 2017 Aug 10.
Published in final edited form as: Small. 2013 Apr 19;9(18):3051–3057. doi: 10.1002/smll.201201921

Figure 7.

Figure 7

HT-29 incubated for 2 days with (a) media only (no particles or drug), (b) particles only unexposed to UV, (c) irinotecan-loaded particles (10% by weight) unexposed to UV, (d) irinotecan-loaded particles (10% by weight) previously exposed to 20 min of UV, and (e) soluble irinotecan (no particles) at the theoretical maximal release concentration. (f) Specific absorbance from XTT assay.